Comment on Six Major Biotech Acquisitions You Could See in 2016 (Part 3)

Six Major Biotech Acquisitions You Could See in 2016 (Part 3)

Medical marijuana is already approved in over half of the U.S. Todd Hagopian says we will soon see a tipping point in which medical marijuana companies will be transformed from fringe enterprises trading at a discount into mainstream biotech companies with premium valuations. Until we reach that tipping point, however, the cannabis-based segment of the biotech sector is ripe for acquisitions.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News